14.00 USD
↗ 0.38 (2.79%)AT CLOSE (11:59 AM EDT)
Shares of Atrium Therapeutics, Inc. Common Stock (RNA) are trading at $13.98. RNA shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9 and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 25, 2026.